A proliferative role for IGFBP-3 is observed in triple-negative breast cancer (TNBC) cells via modulating sphingosine kinase-1 (SphK1) localization to activate EGFR signaling (13, 14). The gene discussed is EGFR; the disease is triple-negative breast carcinoma.